PLASMA GLYCOLATE LEVELS CONTRIBUTE TO DRIVE THE DECISION OF ISOLATED KIDNEY TRANSPLANTATION IN DIALYZED PATIENTS WITH END STAGE KIDNEY DISEASE DUE TO PRIMARY HYPEROXALURIA TYPE 1 TREATED WITH LUMASIRAN. A CASE REPORT
The novelty of our case lies in the methods we adopted to evaluate the lumasiran efficacy during dialysis prior listing for IKT. Specifically, we decided to list the patient for IKT according to the high plasma levels of glycolate reached after lumasiran treatment together with the significant reduction of the pOx.
Authors
- Marta Leporati (ORCID: https://orcid.org/0000-0002-2618-1220)
- Fabiana Brigante
- Marina Di Luca
- Alessandra Calcinari
- Sara Belcastro (ORCID: https://orcid.org/0000-0003-3641-8479)
- Giorgia Mandrile (ORCID: https://orcid.org/0000-0003-0849-2225)
- Andrea Ranghino (ORCID: https://orcid.org/0000-0002-6976-7539)
- Mauro Martello
- Daniela Giachino (ORCID: https://orcid.org/0000-0002-3186-6726)
- Domenica Taruscia
- Roberta Mazzucchelli (ORCID: https://orcid.org/0000-0002-3058-4110)
- Emilio Balestra
- Michele Petrarulo
- Mauro Valente
- Marco Moretti
- Maria Ilaria Moretti
Institutions
- Marche Polytechnic University (IT)
- Azienda Ospedaliero Universitaria Ospedali Riuniti (IT)
- Ospedali Riuniti Marche Nord (IT)
- A. O. Ordine Mauriziano di Torino (IT)
- Ospedale San Luigi Gonzaga (IT)
- Azienda Ospedaliera Universitaria Pisana (IT)
Publication Details
- Journal
- Case Reports in Nephrology and Dialysis
- Published
- 2025-05-23
- DOI
- https://doi.org/10.1159/000546144
- Primary Topic
- Kidney Stones and Urolithiasis Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00